Resources Contact Us Home
Modified factor VIII

Image Number 7 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Multilayered material sheet and process for its preparation
Phosphor adhesive sheet, light emitting diode element including phosphor layer, light emitting diode device, and producing methods thereof
Tap initialization of equalizer based on estimated channel impulse response
Compact light shield for flash photography
Systems and methods for printing images outside a normal color gamut in image forming devices
Detection of bioagents using a shear horizontal surface acoustic wave biosensor
Wireless communication system, associated methods and data structures
  Randomly Featured Patents
Storage system
Information processing terminal and method for preventing an electric shock from the information processing terminal
Extruder welding device
Handheld communications device with automatic alert mode selection
Mounting structure for magnetrons
Semiconductor layer with optical communication between chips disposed therein
Low complexity blind beamforming weight estimation
Low-NO.sub.x staged combustion device for controlled radiative heating in high temperature furnaces
Process for high density flash EPROM cell
Print head for a dot printer